RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재 SCOPUS SCIE

    Effect of lipid on physicochemical properties of solid lipid nanoparticle of paclitaxel

    한글로보기

    https://www.riss.kr/link?id=A104229095

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    The aim of this study was to compare physicochemical properties of solid lipid nanoparticles (SLN) made from different lipids. To make small, stable, uniform and highly encapsulated SLNs, many factors such as the components (lipid, stabilizer) and preparation condition (sonication time, power) can be considered. Out of those, we selected solid lipid as lipid matrix to investigate an effect on SLNs. The SLNs were characterized by particle size, zeta potential, solubility and in vitro release study. In this study,SLNs showed different physicochemical properties and release profiles according to used solid lipid. In case of particle size, M-SLN showed biggest particle size (412.5 ± 29.4 nm) and highest encapsulation efficiency (61.2 ± 4.8 %). And, B-SLN showed highest cumulative drug percentage (85.0 ± 1.7 %, 24 h) in release study.
    These results suggest that lipids type affect physicochemical properties and release profile of SLN.
    번역하기

    The aim of this study was to compare physicochemical properties of solid lipid nanoparticles (SLN) made from different lipids. To make small, stable, uniform and highly encapsulated SLNs, many factors such as the components (lipid, stabilizer) and pre...

    The aim of this study was to compare physicochemical properties of solid lipid nanoparticles (SLN) made from different lipids. To make small, stable, uniform and highly encapsulated SLNs, many factors such as the components (lipid, stabilizer) and preparation condition (sonication time, power) can be considered. Out of those, we selected solid lipid as lipid matrix to investigate an effect on SLNs. The SLNs were characterized by particle size, zeta potential, solubility and in vitro release study. In this study,SLNs showed different physicochemical properties and release profiles according to used solid lipid. In case of particle size, M-SLN showed biggest particle size (412.5 ± 29.4 nm) and highest encapsulation efficiency (61.2 ± 4.8 %). And, B-SLN showed highest cumulative drug percentage (85.0 ± 1.7 %, 24 h) in release study.
    These results suggest that lipids type affect physicochemical properties and release profile of SLN.

    더보기

    참고문헌 (Reference)

    1 Anderson M, "The effect of different lipid componentson the in vitro stability and release kinetics of liposomeformulations" 11 (11): 33-39, 2004

    2 Spada G, "Solid lipidnanoparticles with and without hydroxypropyl-b-cyclodextrin: acomparative study of nanoparticles designed for colonic drugdelivery" 23 (23): 095101-, 2012

    3 Wissing SA, "Solid lipid nanoparticlesfor parenteral drug delivery" 56 : 1257-1272, 2004

    4 Mahnert W, "Solid lipid nanoparticles: production,characterization and applications" 47 (47): 165-196, 2001

    5 Mukherjee S, "Solid lipid nanoparticles: amodern formulation approach in drug delivery system" 71 (71): 349-358, 2009

    6 Padois K, "Solid lipid nanoparticles suspension versus commercial solutionsfor dermal delivery of minoxidil" 416 (416): 300-304, 2011

    7 Muller RH, "Solid lipid nanoparticles (SLN)for controlled drug delivery—a review of the state of the art" 50 (50): 161-177, 2000

    8 Marengo E, "Scale-up of preparation process of solid lipid nanospheres. Part I" 205 (205): 3-13, 2000

    9 임수정, "Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles" ELSEVIER SCI LTD 28 : 2137-2146, 2007

    10 Joseph S, "Preparation of nanoemulsions an solidlipid nanoparticles by premix membrane emulsification" 101 (101): 2479-2489, 2012

    1 Anderson M, "The effect of different lipid componentson the in vitro stability and release kinetics of liposomeformulations" 11 (11): 33-39, 2004

    2 Spada G, "Solid lipidnanoparticles with and without hydroxypropyl-b-cyclodextrin: acomparative study of nanoparticles designed for colonic drugdelivery" 23 (23): 095101-, 2012

    3 Wissing SA, "Solid lipid nanoparticlesfor parenteral drug delivery" 56 : 1257-1272, 2004

    4 Mahnert W, "Solid lipid nanoparticles: production,characterization and applications" 47 (47): 165-196, 2001

    5 Mukherjee S, "Solid lipid nanoparticles: amodern formulation approach in drug delivery system" 71 (71): 349-358, 2009

    6 Padois K, "Solid lipid nanoparticles suspension versus commercial solutionsfor dermal delivery of minoxidil" 416 (416): 300-304, 2011

    7 Muller RH, "Solid lipid nanoparticles (SLN)for controlled drug delivery—a review of the state of the art" 50 (50): 161-177, 2000

    8 Marengo E, "Scale-up of preparation process of solid lipid nanospheres. Part I" 205 (205): 3-13, 2000

    9 임수정, "Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles" ELSEVIER SCI LTD 28 : 2137-2146, 2007

    10 Joseph S, "Preparation of nanoemulsions an solidlipid nanoparticles by premix membrane emulsification" 101 (101): 2479-2489, 2012

    11 Carbone C, "Preparation and optimization of PIT solid lipid nanoparticles viastatistical factorial design" 49 : 110-117, 2012

    12 HuFQ JiangSP, "Preparation and characterization ofstearic acid nanostructured lipid carriers by solvent diffusionmethod in an aqueous system" 45 : 167-173, 2005

    13 Kheradmandnia S, "Preparation and characterization of ketoprofen-loadedsolid lipid nanoparticles made from beeswax and carnauba wax" 6 (6): 753-759, 2010

    14 Sievens-Figueroa L, "Preparation and characterization of hydroxypropyl methyl cellulosefilms containing stable BCS Class II drug nanoparticlesfor pharmaceutical applications" 423 (423): 496-508, 2012

    15 Noack A, "Physicochemical characterizationof curcuminoid-loaded solid lipid nanoparticles" 423 (423): 440-451, 2012

    16 Shenoy VS, "Paclitaxel-loaded glycerylpalmitostearate nanoparticles: in vitro release and cytotoxiciactivity" 17 (17): 304-310, 2009

    17 Hurst SJ, "Maximizing DNAloading on a range of gold nanoparticle sizes" 78 (78): 13-18, 2006

    18 Ghadiri M, "Loading hydrophilic drug in solid lipidmedia as nanoparticles : statistical modeling of entrapmentefficiency and particle size" 424 (424): 128-137, 2012

    19 Nesseem D, "Formulation of sunscreens with enhancement sunprotection factor response based on solid lipid nanoparticles" 33 (33): 70-79, 2011

    20 Muller RH, "Fat emulsions for parenteralnutrition. I. Evaluation of microscopic and laser light scatteringmethods for the determination of the physical stability" 11 : 223-272, 1992

    21 Song X, "Dual agents loaded PLGA nanoparticles: systematicstudy of particle size and drug entrapment efficiency" 69 (69): 445-453, 2008

    22 Kumar VV, "Development and evaluation of nitrendipineloaded solid lipid nanoparticles: influence of wax and glyceridelipids on plasma pharmacokinetics" 335 (335): 167-175, 2007

    더보기

    동일학술지(권/호) 다른 논문

    동일학술지 더보기

    더보기

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2023 평가 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
    2020-01-01 등재 등재학술지 유지 (해외등재 학술지 평가) KCI등재
    2010-06-09 학술지명변경 한글명 : 약제학회지 -> Journal of Pharmaceutical Investigation
    외국어명 : Jorunal of Korean Pharmaceutical Sciences -> Journal of Pharmaceutical Investigation
    KCI등재
    2010-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2008-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2006-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2005-06-16 학회명변경 영문명 : The Korean Society Of Pharmaceutics -> The Korean Society of Pharmaceutical Sciences and Technology KCI등재
    2004-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2001-07-01 등재 등재학술지 선정 (등재후보2차) KCI등재
    1999-01-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 0.18 0.18 0.14
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0.13 0.11 0.374 0.02
    더보기

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼